Tekla Healthcare Opportunities Fund (THQ) N-PX Annual report of proxy voting record

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB APPROVAL
	OMB Number:  3235-0582
	Expires:  May 31, 2021
	Estimated average burden
	hours per response........7.2

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number  811-06565

Tekla Healthcare Opportunites Fund

(Exact name of registrant as specified in charter)

100 Federal Street, 19th Floor, Boston, MA	02110
(Address of principal executive offices)	(Zip code)

Laura Woodward

Tekla Healthcare Opportunities Fund

100 Federal Street, 19^th Floor, Boston MA 02110

(Name and address of agent for service)

Registrant’s telephone number, including area code:  617-772-8500

Date of fiscal year end:  September 30

Date of reporting period:  7/1/19-6/30/20

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 Item 1. Proxy Voting Record.

THQ Vote Summary

ABBOTT LABORATORIES

Security	002824100	Meeting Type	Annual
Ticker Symbol	ABT	Meeting Date	24-Apr-2020
Record Date	26-Feb-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	R.J. Alpern		For	For
	2	R.S. Austin		For	For
	3	S.E. Blount		For	For
	4	R.B. Ford		For	For
	5	M.A. Kumbier		For	For
	6	E.M. Liddy		For	For
	7	D.W. McDew		For	For
	8	N. McKinstry		For	For
	9	P.N. Novakovic		For	For
	10	W.A. Osborn		For	For
	11	D.J. Starks		For	For
	12	J.G. Stratton		For	For
	13	G.F. Tilton		For	For
	14	M.D. White		For	For
2.	Ratification of Ernst & Young LLP as Auditors.		Management	For	For
3.	Say on Pay - An Advisory Vote to Approve Executive Compensation.		Management	For	For
4.	Shareholder Proposal - Lobbying Disclosure.		Shareholder	Against	For
5.	Shareholder Proposal - Non-GAAP Financial Performance Metrics Disclosure.		Shareholder	Against	For
6.	Shareholder Proposal - Shareholder Voting on By-Law Amendments.		Shareholder	Against	For
7.	Shareholder Proposal - Simple Majority Vote.		Shareholder	Against	For

ABBVIE INC.

Security	00287Y109	Meeting Type	Annual
Ticker Symbol	ABBV	Meeting Date	08-May-2020
Record Date	13-Mar-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Robert J. Alpern		For	For
	2	Edward M. Liddy		For	For
	3	Melody B. Meyer		For	For
	4	Frederick H. Waddell		For	For
2.	Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2020		Management	For	For
3.	Say on Pay - An advisory vote on the approval of executive compensation		Management	For	For
4.	Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting		Management	For	For
5.	Stockholder Proposal - to Issue an Annual Report on Lobbying		Shareholder	Against	For
6.	Stockholder Proposal - to Adopt a Policy to Require Independent Chairman		Shareholder	For	Against
7.	Stockholder Proposal - to Issue a Compensation Committee Report on Drug Pricing		Shareholder	Against	For

ABIOMED, INC.

Security	003654100	Meeting Type	Annual
Ticker Symbol	ABMD	Meeting Date	07-Aug-2019
Record Date	10-Jun-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Michael R. Minogue		For	For
	2	Martin P. Sutter		For	For
2.	Approval, by non-binding advisory vote, of the compensation of our named executive officers.		Management	For	For
3.	Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2020.		Management	For	For

ACADIA HEALTHCARE COMPANY, INC.

Security	00404A109	Meeting Type	Annual
Ticker Symbol	ACHC	Meeting Date	07-May-2020
Record Date	12-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Wade D. Miquelon	Management	For	For
1B.	Election of Director: William M. Petrie, M.D.	Management	For	For
2.	Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement.	Management	For	For
3.	Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For

AGILENT TECHNOLOGIES, INC.

Security	00846U101	Meeting Type	Annual
Ticker Symbol	A	Meeting Date	17-Apr-2020
Record Date	22-Jan-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director for a three-year term: Heidi Kunz	Management	For	For
1.2	Election of Director for a three-year term: Sue H. Rataj	Management	For	For
1.3	Election of Director for a three-year term: George A. Scangos, Ph.D.	Management	For	For
1.4	Election of Director for a three-year term: Dow R. Wilson	Management	For	For
2.	To approve the Agilent Technologies, Inc. 2020 Employee Stock Purchase Plan.	Management	For	For
3.	To approve, on a non-binding advisory basis, the compensation of Agilent's named executive officers.	Management	For	For
4.	To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as Agilent's independent registered public accounting firm.	Management	For	For

ALEXION PHARMACEUTICALS, INC.

Security	015351109	Meeting Type	Annual
Ticker Symbol	ALXN	Meeting Date	13-May-2020
Record Date	16-Mar-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Felix J. Baker		For	For
	2	David R. Brennan		For	For
	3	Christopher J. Coughlin		For	For
	4	Deborah Dunsire		For	For
	5	Paul A. Friedman		For	For
	6	Ludwig N. Hantson		For	For
	7	John T. Mollen		For	For
	8	Francois Nader		For	For
	9	Judith A. Reinsdorf		For	For
	10	Andreas Rummelt		For	For
2.	Proposal No. 2 - Ratification of appointment by the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.		Management	For	For
3.	Proposal No. 3 - Approval of a non-binding advisory vote of the 2019 compensation paid to Alexion's named executive officers.		Management	For	For
4.	Proposal No. 4 - Shareholder proposal requesting certain By-law amendments to lower the threshold for shareholders to call a special meeting.		Shareholder	Against	For

ALIGN TECHNOLOGY, INC.

Security	016255101	Meeting Type	Annual
Ticker Symbol	ALGN	Meeting Date	20-May-2020
Record Date	25-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kevin J. Dallas	Management	For	For
1B.	Election of Director: Joseph M. Hogan	Management	For	For
1C.	Election of Director: Joseph Lacob	Management	For	For
1D.	Election of Director: C. Raymond Larkin, Jr.	Management	For	For
1E.	Election of Director: George J. Morrow	Management	For	For
1F.	Election of Director: Anne M. Myong	Management	For	For
1G.	Election of Director: Thomas M. Prescott	Management	For	For
1H.	Election of Director: Andrea L. Saia	Management	For	For
1I.	Election of Director: Greg J. Santora	Management	For	For
1J.	Election of Director: Susan E. Siegel	Management	For	For
1K.	Election of Director: Warren S. Thaler	Management	For	For
2.	RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2020.	Management	For	For
3.	ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.	Management	For	For

ALLERGAN PLC

Security	G0177J108	Meeting Type	Special
Ticker Symbol	AGN	Meeting Date	14-Oct-2019
Record Date	16-Sep-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	COURT MEETING: Approve the scheme of arrangement.	Management	For	For
2.	Extraordinary General Meeting: Approve the scheme of arrangement and authorize the directors of Allergan plc to take all such actions as they consider necessary or appropriate for carrying the scheme of arrangement into effect.	Management	For	For
3.	Extraordinary General Meeting: Approve the cancellation of any Allergan plc ordinary shares in issue at 11:59 p.m., Irish time, on the day before the Irish High Court hearing to sanction the scheme (excluding, in any case, any Allergan plc ordinary shares which are held from time to time by AbbVie Inc., Acquirer Sub (as defined in the scheme of arrangement) or any other subsidiary of AbbVie Inc., if any).	Management	For	For
4.	Extraordinary General Meeting: Authorize the directors of Allergan plc to allot and issue new Allergan plc shares, fully paid up, to Acquirer Sub and/or its nominee(s) in connection with effecting the scheme.	Management	For	For
5.	Extraordinary General Meeting: Amend the articles of association of Allergan plc so that any ordinary shares of Allergan plc that are issued on or after the Voting Record Time (as defined in the scheme of arrangement) to persons other than Acquirer Sub or its nominees will either be subject to the terms of the scheme or will be immediately and automatically acquired by Acquirer Sub and/or its nominee(s) for the scheme consideration.	Management	For	For
6.	Extraordinary General Meeting: Approve, on a non- binding, advisory basis, specified compensatory arrangements between Allergan plc and its named executive officers relating to the transaction.	Management	For	For
7.	Extraordinary General Meeting: Approve any motion by the Chairman to adjourn the extraordinary general meeting, or any adjournments thereof, to solicit additional proxies in favor of the approval of the resolutions if there are insufficient votes at the time of the extraordinary general meeting to approve resolutions 2 through 5.	Management	For	For

AMERISOURCEBERGEN CORPORATION

Security	03073E105	Meeting Type	Annual
Ticker Symbol	ABC	Meeting Date	05-Mar-2020
Record Date	06-Jan-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Ornella Barra	Management	For	For
1B.	Election of Director: Steven H. Collis	Management	For	For
1C.	Election of Director: D. Mark Durcan	Management	For	For
1D.	Election of Director: Richard W. Gochnauer	Management	For	For
1E.	Election of Director: Lon R. Greenberg	Management	For	For
1F.	Election of Director: Jane E. Henney, M.D.	Management	For	For
1G.	Election of Director: Kathleen W. Hyle	Management	For	For
1H.	Election of Director: Michael J. Long	Management	For	For
1I.	Election of Director: Henry W. McGee	Management	For	For
1J.	Election of Director: Dennis M. Nally	Management	For	For
2.	Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2020.	Management	For	For
3.	Advisory vote to approve the compensation of named executive officers.	Management	For	For
4.	Stockholder proposal, if properly presented, to permit stockholders to act by written consent.	Shareholder	Against	For
5.	Stockholder proposal, if properly presented, regarding the use of a deferral period for certain compensation of senior executives.	Shareholder	Against	For

AMGEN INC.

Security	031162100	Meeting Type	Annual
Ticker Symbol	AMGN	Meeting Date	19-May-2020
Record Date	20-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Dr. Wanda M. Austin	Management	For	For
1B.	Election of Director: Mr. Robert A. Bradway	Management	For	For
1C.	Election of Director: Dr. Brian J. Druker	Management	For	For
1D.	Election of Director: Mr. Robert A. Eckert	Management	For	For
1E.	Election of Director: Mr. Greg C. Garland	Management	For	For
1F.	Election of Director: Mr. Fred Hassan	Management	For	For
1G.	Election of Director: Mr. Charles M. Holley, Jr.	Management	For	For
1H.	Election of Director: Dr. Tyler Jacks	Management	For	For
1I.	Election of Director: Ms. Ellen J. Kullman	Management	For	For
1J.	Election of Director: Dr. Ronald D. Sugar	Management	For	For
1K.	Election of Director: Dr. R. Sanders Williams	Management	For	For
2.	Advisory vote to approve our executive compensation.	Management	For	For
3.	To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2020.	Management	For	For
4.	Stockholder proposal to require an independent board chair.	Shareholder	For	Against

ANTHEM, INC.

Security	036752103	Meeting Type	Annual
Ticker Symbol	ANTM	Meeting Date	21-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Gail K. Boudreaux	Management	For	For
1.2	Election of Director: R. Kerry Clark	Management	For	For
1.3	Election of Director: Robert L. Dixon, Jr.	Management	For	For
2.	Advisory vote to approve the compensation of our named executive officers.	Management	For	For
3.	To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2020.	Management	For	For
4.	Shareholder proposal to allow shareholders owning 10% or more of our common stock to call a special meeting of shareholders.	Shareholder	Against	For

ATRECA INC

Security	04965G109	Meeting Type	Annual
Ticker Symbol	BCEL	Meeting Date	10-Jun-2020
Record Date	17-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	David Lacey, MD		For	For
	2	Lindsey Rolfe, MBChB		For	For
2.	Ratification of the selection of OUM & Co. LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020.		Management	For	For

BAXTER INTERNATIONAL INC.

Security	071813109	Meeting Type	Annual
Ticker Symbol	BAX	Meeting Date	05-May-2020
Record Date	12-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: José (Joe) E. Almeida	Management	For	For
1B.	Election of Director: Thomas F. Chen	Management	For	For
1C.	Election of Director: John D. Forsyth	Management	For	For
1D.	Election of Director: James R. Gavin III	Management	For	For
1E.	Election of Director: Peter S. Hellman	Management	For	For
1F.	Election of Director: Michael F. Mahoney	Management	For	For
1G.	Election of Director: Patricia B. Morrison	Management	For	For
1H.	Election of Director: Stephen N. Oesterle	Management	For	For
1I.	Election of Director: Cathy R. Smith	Management	For	For
1J.	Election of Director: Thomas T. Stallkamp	Management	For	For
1K.	Election of Director: Albert P.L. Stroucken	Management	For	For
1L.	Election of Director: Amy A. Wendell	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation	Management	For	For
3.	Ratification of Appointment of Independent Registered Public Accounting Firm	Management	For	For
4.	Stockholder Proposal - Independent Board Chairman	Shareholder	For	Against
5.	Stockholder Proposal - Right to Act by Written Consent	Shareholder	For	Against

BECTON, DICKINSON AND COMPANY

Security	075887109	Meeting Type	Annual
Ticker Symbol	BDX	Meeting Date	28-Jan-2020
Record Date	09-Dec-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Catherine M. Burzik	Management	For	For
1B.	Election of Director: R. Andrew Eckert	Management	For	For
1C.	Election of Director: Vincent A. Forlenza	Management	For	For
1D.	Election of Director: Claire M. Fraser	Management	For	For
1E.	Election of Director: Jeffrey W. Henderson	Management	For	For
1F.	Election of Director: Christopher Jones	Management	For	For
1G.	Election of Director: Marshall O. Larsen	Management	For	For
1H.	Election of Director: David F. Melcher	Management	For	For
1I.	Election of Director: Thomas E. Polen	Management	For	For
1J.	Election of Director: Claire Pomeroy	Management	For	For
1K.	Election of Director: Rebecca W. Rimel	Management	For	For
1L.	Election of Director: Timothy M. Ring	Management	For	For
1M.	Election of Director: Bertram L. Scott	Management	For	For
2.	Ratification of selection of independent registered public accounting firm.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	Approval of amendment to BD's 2004 Employee and Director Equity-Based Compensation Plan.	Management	For	For
5.	Approval of French Addendum to BD'S 2004 Employee and Director Equity-Based Compensation Plan.	Management	For	For
6.	Shareholder proposal regarding special shareholder meetings.	Shareholder	Against	For

BIOGEN INC.

Security	09062X103	Meeting Type	Annual
Ticker Symbol	BIIB	Meeting Date	03-Jun-2020
Record Date	06-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director for a one year term extending until the 2021 annual meeting: Alexander J. Denner	Management	For	For
1B.	Election of Director for a one year term extending until the 2021 annual meeting: Caroline D. Dorsa	Management	For	For
1C.	Election of Director for a one year term extending until the 2021 annual meeting: William A. Hawkins	Management	For	For
1D.	Election of Director for a one year term extending until the 2021 annual meeting: Nancy L. Leaming	Management	For	For
1E.	Election of Director for a one year term extending until the 2021 annual meeting: Jesus B. Mantas	Management	For	For
1F.	Election of Director for a one year term extending until the 2021 annual meeting: Richard C. Mulligan	Management	For	For
1G.	Election of Director for a one year term extending until the 2021 annual meeting: Robert W. Pangia	Management	For	For
1H.	Election of Director for a one year term extending until the 2021 annual meeting: Stelios Papadopoulos	Management	For	For
1I.	Election of Director for a one year term extending until the 2021 annual meeting: Brian S. Posner	Management	For	For
1J.	Election of Director for a one year term extending until the 2021 annual meeting: Eric K. Rowinsky	Management	For	For
1K.	Election of Director for a one year term extending until the 2021 annual meeting: Stephen A. Sherwin	Management	For	For
1L.	Election of Director for a one year term extending until the 2021 annual meeting: Michel Vounatsos	Management	For	For
2.	To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
3.	Say on Pay - To approve an advisory vote on executive compensation.	Management	For	For

BOSTON SCIENTIFIC CORPORATION

Security	101137107	Meeting Type	Annual
Ticker Symbol	BSX	Meeting Date	07-May-2020
Record Date	13-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Nelda J. Connors	Management	For	For
1B.	Election of Director: Charles J. Dockendorff	Management	For	For
1C.	Election of Director: Yoshiaki Fujimori	Management	For	For
1D.	Election of Director: Donna A. James	Management	For	For
1E.	Election of Director: Edward J. Ludwig	Management	For	For
1F.	Election of Director: Stephen P. MacMillan	Management	For	For
1G.	Election of Director: Michael F. Mahoney	Management	For	For
1H.	Election of Director: David J. Roux	Management	For	For
1I.	Election of Director: John E. Sununu	Management	For	For
1J.	Election of Director: Ellen M. Zane	Management	For	For
2.	To approve, on a non-binding, advisory basis, named executive officer compensation.	Management	For	For
3.	To approve an amendment and restatement of the Company's 2011 Long-Term Incentive Plan.	Management	For	For
4.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2020 fiscal year.	Management	For	For
5.	To consider and vote upon a stockholder proposal requesting a report on inclusion of non-management employee representation on the Board of Directors.	Shareholder	Against	For

BRISTOL-MYERS SQUIBB COMPANY

Security	110122108	Meeting Type	Annual
Ticker Symbol	BMY	Meeting Date	05-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Peter J. Arduini	Management	For	For
1B.	Election of Director: Robert Bertolini	Management	For	For
1C.	Election of Director: Michael W. Bonney	Management	For	For
1D.	Election of Director: Giovanni Caforio, M.D.	Management	For	For
1E.	Election of Director: Matthew W. Emmens	Management	For	For
1F.	Election of Director: Julia A. Haller, M.D.	Management	For	For
1G.	Election of Director: Dinesh C. Paliwal	Management	For	For
1H.	Election of Director: Theodore R. Samuels	Management	For	For
1I.	Election of Director: Vicki L. Sato, Ph.D.	Management	For	For
1J.	Election of Director: Gerald L. Storch	Management	For	For
1K.	Election of Director: Karen H. Vousden, Ph.D.	Management	For	For
1L.	Election of Director: Phyllis R. Yale	Management	For	For
2.	Advisory vote to approve the compensation of our Named Executive Officers.	Management	For	For
3.	Ratification of the appointment of an independent registered public accounting firm.	Management	For	For
4.	Shareholder Proposal on Separate Chair & CEO.	Shareholder	For	Against
5.	Shareholder Proposal on Shareholder Right to Act by Written Consent.	Shareholder	Against	For

CARDINAL HEALTH, INC.

Security	14149Y108	Meeting Type	Annual
Ticker Symbol	CAH	Meeting Date	06-Nov-2019
Record Date	09-Sep-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Colleen F. Arnold	Management	For	For
1B.	Election of Director: Carrie S. Cox	Management	For	For
1C.	Election of Director: Calvin Darden	Management	For	For
1D.	Election of Director: Bruce L. Downey	Management	For	For
1E.	Election of Director: Patricia A. Hemingway Hall	Management	For	For
1F.	Election of Director: Akhil Johri	Management	For	For
1G.	Election of Director: Michael C. Kaufmann	Management	For	For
1H.	Election of Director: Gregory B. Kenny	Management	For	For
1I.	Election of Director: Nancy Killefer	Management	For	For
1J.	Election of Director: J. Michael Losh	Management	For	For
1K.	Election of Director: Dean A. Scarborough	Management	For	For
1L.	Election of Director: John H. Weiland	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2020.	Management	For	For
3.	To approve, on a non-binding advisory basis, the compensation of our named executive officers.	Management	For	For

CENTENE CORPORATION

Security	15135B101	Meeting Type	Annual
Ticker Symbol	CNC	Meeting Date	28-Apr-2020
Record Date	28-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	ELECTION OF DIRECTOR: Michael F. Neidorff	Management	For	For
1B.	ELECTION OF DIRECTOR: H. James Dallas	Management	For	For
1C.	ELECTION OF DIRECTOR: Robert K. Ditmore	Management	For	For
1D.	ELECTION OF DIRECTOR: Richard A. Gephardt	Management	For	For
1E.	ELECTION OF DIRECTOR: Lori J. Robinson	Management	For	For
1F.	ELECTION OF DIRECTOR: William L. Trubeck	Management	For	For
2.	ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.	Management	For	For
3.	RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2020.	Management	For	For
4.	APPROVAL OF AMENDMENT TO THE 2002 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED AND RESTATED.	Management	For	For
5.	THE STOCKHOLDER PROPOSAL ON POLITICAL SPENDING DISCLOSURES AS DESCRIBED IN THE PROXY STATEMENT.	Shareholder	Against	For
6.	THE STOCKHOLDER PROPOSAL ON THE ELIMINATION OF SUPERMAJORITY VOTING PROVISIONS AS DESCRIBED IN THE PROXY STATEMENT.	Shareholder	Against	For

CERNER CORPORATION

Security	156782104	Meeting Type	Annual
Ticker Symbol	CERN	Meeting Date	22-May-2020
Record Date	24-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Class I Director: Julie L. Gerberding, M.D., M.P.H.	Management	For	For
1b.	Election of Class I Director: Brent Shafer	Management	For	For
1c.	Election of Class I Director: William D. Zollars	Management	For	For
2.	Ratification of the appointment of KPMG LLP as the independent registered public accounting firm of Cerner Corporation for 2020.	Management	For	For
3.	Approval, on an advisory basis, of the compensation of our Named Executive Officers.	Management	For	For
4.	Approval of the proposed amendment to our Third Restated Certificate of Incorporation to declassify the Board of Directors.	Management	For	For
5.	Approval of the proposed amendment to our Third Restated Certificate of Incorporation to amend the advance notice provisions for director nominations.	Management	For	For

CHARLES RIVER LABORATORIES INTL., INC.

Security	159864107	Meeting Type	Annual
Ticker Symbol	CRL	Meeting Date	06-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: James C. Foster	Management	For	For
1B.	Election of Director: Nancy C. Andrews	Management	For	For
1C.	Election of Director: Robert J. Bertolini	Management	For	For
1D.	Election of Director: Stephen D. Chubb	Management	For	For
1E.	Election of Director: Deborah T. Kochevar	Management	For	For
1F.	Election of Director: Martin W. MacKay	Management	For	For
1G.	Election of Director: George E. Massaro	Management	For	For
1H.	Election of Director: George M. Milne, Jr.	Management	For	For
1I.	Election of Director: C. Richard Reese	Management	For	For
1J.	Election of Director: Richard F. Wallman	Management	For	For
1K.	Election of Director: Virginia M. Wilson	Management	For	For
2.	Say on Pay - An advisory vote to approve our executive compensation.	Management	For	For
3.	Proposal to Amend the 2018 Incentive Plan.	Management	For	For
4.	Proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accountants for the fiscal year ending December 26, 2020	Management	For	For

CIGNA CORPORATION

Security	125523100	Meeting Type	Annual
Ticker Symbol	CI	Meeting Date	22-Apr-2020
Record Date	24-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: David M. Cordani	Management	For	For
1B.	Election of Director: William J. DeLaney	Management	For	For
1C.	Election of Director: Eric J. Foss	Management	For	For
1D.	Election of Director: Elder Granger, MD, MG, USA	Management	For	For
1E.	Election of Director: Isaiah Harris, Jr.	Management	For	For
1F.	Election of Director: Roman Martinez IV	Management	For	For
1G.	Election of Director: Kathleen M. Mazzarella	Management	For	For
1H.	Election of Director: Mark B. McClellan, MD, PhD	Management	For	For
1I.	Election of Director: John M. Partridge	Management	For	For
1J.	Election of Director: William L. Roper, MD, MPH	Management	For	For
1K.	Election of Director: Eric C. Wiseman	Management	For	For
1L.	Election of Director: Donna F. Zarcone	Management	For	For
2.	Advisory approval of Cigna's executive compensation.	Management	For	For
3.	Ratification of appointment of PricewaterhouseCoopers LLP as Cigna's independent registered public accounting firm for 2020.	Management	For	For
4.	Shareholder proposal - Shareholder right to call a special meeting.	Shareholder	Against	For
5.	Shareholder proposal - Gender pay gap report.	Shareholder	Against	For

COMMUNITY HEALTH SYSTEMS, INC.

Security	203668108	Meeting Type	Annual
Ticker Symbol	CYH	Meeting Date	12-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: John A. Clerico	Management	For	For
1B.	Election of Director: Michael Dinkins	Management	For	For
1C.	Election of Director: James S. Ely III	Management	For	For
1D.	Election of Director: John A. Fry	Management	For	For
1E.	Election of Director: Tim L. Hingtgen	Management	For	For
1F.	Election of Director: Elizabeth T. Hirsch	Management	For	For
1G.	Election of Director: William Norris Jennings, M.D.	Management	For	For
1H.	Election of Director: K. Ranga Krishnan, MBBS	Management	For	For
1I.	Election of Director: Julia B. North	Management	For	For
1J.	Election of Director: Wayne T. Smith	Management	For	For
1K.	Election of Director: H. James Williams, Ph.D.	Management	For	For
2.	Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.	Management	For	For
3.	Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors on March 20, 2020, subject to stockholder approval.	Management	For	For
4.	Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For

CVS HEALTH CORPORATION

Security	126650100	Meeting Type	Annual
Ticker Symbol	CVS	Meeting Date	14-May-2020
Record Date	18-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Fernando Aguirre	Management	For	For
1B.	Election of Director: C. David Brown II	Management	For	For
1C.	Election of Director: Alecia A. DeCoudreaux	Management	For	For
1D.	Election of Director: Nancy-Ann M. DeParle	Management	For	For
1E.	Election of Director: David W. Dorman	Management	For	For
1F.	Election of Director: Roger N. Farah	Management	For	For
1G.	Election of Director: Anne M. Finucane	Management	For	For
1H.	Election of Director: Edward J. Ludwig	Management	For	For
1I.	Election of Director: Larry J. Merlo	Management	For	For
1J.	Election of Director: Jean-Pierre Millon	Management	For	For
1K.	Election of Director: Mary L. Schapiro	Management	For	For
1L.	Election of Director: William C. Weldon	Management	For	For
1M.	Election of Director: Tony L. White	Management	For	For
2.	Ratification of the appointment of our independent registered public accounting firm for 2020.	Management	For	For
3.	Say on Pay, a proposal to approve, on an advisory basis, the Company's executive compensation.	Management	For	For
4.	Proposal to amend the Company's 2017 Incentive Compensation Plan to increase the number of shares authorized to be issued under the Plan.	Management	For	For
5.	Proposal to amend the Company's 2007 Employee Stock Purchase Plan to increase the number of shares available for sale under the Plan.	Management	For	For
6.	Stockholder proposal for reducing the ownership threshold to request a stockholder action by written consent.	Shareholder	Against	For
7.	Stockholder proposal regarding our independent Board Chair.	Shareholder	Against	For

DANAHER CORPORATION

Security	235851102	Meeting Type	Annual
Ticker Symbol	DHR	Meeting Date	05-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Linda Hefner Filler	Management	For	For
1B.	Election of Director: Thomas P. Joyce, Jr.	Management	For	For
1C.	Election of Director: Teri List-Stoll	Management	For	For
1D.	Election of Director: Walter G. Lohr, Jr.	Management	For	For
1E.	Election of Director: Jessica L. Mega, MD, MPH	Management	For	For
1F.	Election of Director: Pardis C. Sabeti, MD, D. Phil.	Management	For	For
1G.	Election of Director: Mitchell P. Rales	Management	For	For
1H.	Election of Director: Steven M. Rales	Management	For	For
1I.	Election of Director: John T. Schwieters	Management	For	For
1J.	Election of Director: Alan G. Spoon	Management	For	For
1K.	Election of Director: Raymond C. Stevens, Ph.D.	Management	For	For
1L.	Election of Director: Elias A. Zerhouni, MD	Management	For	For
2.	To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2020	Management	For	For
3.	To approve on an advisory basis the Company's named executive officer compensation	Management	For	For
4.	To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10%	Shareholder	Against	For

DECIPHER BIOSCIENCES, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	16-Sep-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1	Amendment of 2018 Equity Incentive Plan	Management	For	For
2	General Authorizing Resolution	Management	For	For

DECIPHER BIOSCIENCES, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	14-May-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Amendment and Restatement of Certification of Incorporation	Management	For	For
2.	Series 4 Preferred Stock and Note Financing	Management	For	For
3.	Amendment of 2018 Equity Incentive Plan	Management	For	For
4.	General Authorizing Resolution	Management	For	For

DENTSPLY SIRONA INC.

Security	24906P109	Meeting Type	Annual
Ticker Symbol	XRAY	Meeting Date	20-May-2020
Record Date	23-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Michael C. Alfano	Management	For	For
1B.	Election of Director: Eric K. Brandt	Management	For	For
1C.	Election of Director: Donald M. Casey Jr.	Management	For	For
1D.	Election of Director: Willie A. Deese	Management	For	For
1E.	Election of Director: Betsy D. Holden	Management	For	For
1F.	Election of Director: Arthur D. Kowaloff	Management	For	For
1G.	Election of Director: Harry M. Kraemer Jr.	Management	For	For
1H.	Election of Director: Gregory T. Lucier	Management	For	For
1I.	Election of Director: Francis J. Lunger	Management	For	For
1J.	Election of Director: Leslie F. Varon	Management	For	For
1K.	Election of Director: Janet S. Vergis	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for 2020.	Management	For	For
3.	Approval, by non-binding vote, of the Company's executive compensation.	Management	For	For

DIVERSIFIED HEALTHCARE TRUST

Security	25525P107	Meeting Type	Annual
Ticker Symbol	DHC	Meeting Date	19-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Independent Class III Trustee: Jeffrey P. Somers	Management	For	For
2.	Approve an amendment to the Company's Declaration of Trust to provide for the annual election of all Trustees.	Management	For	For
3.	Advisory vote to approve executive compensation.	Management	For	For
4.	Ratification of the appointment of Ernst & Young LLP as independent auditors to serve for the 2020 fiscal year.	Management	For	For

EDWARDS LIFESCIENCES CORPORATION

Security	28176E108	Meeting Type	Annual
Ticker Symbol	EW	Meeting Date	07-May-2020
Record Date	13-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Michael A. Mussallem	Management	For	For
1B.	Election of Director: Kieran T. Gallahue	Management	For	For
1C.	Election of Director: Leslie S. Heisz	Management	For	For
1D.	Election of Director: William J. Link, Ph.D.	Management	For	For
1E.	Election of Director: Steven R. Loranger	Management	For	For
1F.	Election of Director: Martha H. Marsh	Management	For	For
1G.	Election of Director: Ramona Sequeira	Management	For	For
1H.	Election of Director: Nicholas J. Valeriani	Management	For	For
2.	ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS.	Management	For	For
3.	APPROVAL OF THE 2020 NONEMPLOYEE DIRECTORS STOCK INCENTIVE PROGRAM.	Management	For	For
4.	APPROVAL OF AMENDMENT OF THE CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FOR THE PURPOSE OF EFFECTING A THREE-FOR-ONE STOCK SPLIT.	Management	For	For
5.	RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	Management	For	For
6.	ADVISORY VOTE ON A STOCKHOLDER PROPOSAL REGARDING ACTION BY WRITTEN CONSENT.	Shareholder	Against	For

ELI LILLY AND COMPANY

Security	532457108	Meeting Type	Annual
Ticker Symbol	LLY	Meeting Date	04-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: M. L. Eskew	Management	For	For
1B.	Election of Director: W. G. Kaelin, Jr.	Management	For	For
1C.	Election of Director: D. A. Ricks	Management	For	For
1D.	Election of Director: M. S. Runge	Management	For	For
1E.	Election of Director: K. Walker	Management	For	For
2.	Approval, by non-binding vote, of the compensation paid to the company's named executive officers.	Management	For	For
3.	Ratification of Ernst & Young LLP as the independent auditor for 2020.	Management	For	For
4.	Approve amendments to the Articles of Incorporation to eliminate the classified board structure.	Management	For	For
5.	Approve amendments to the Articles of Incorporation to eliminate supermajority voting provisions.	Management	For	For
6.	Shareholder proposal to disclose direct and indirect lobbying activities and expenditures.	Shareholder	Against	For
7.	Shareholder proposal to publish a report on the effectiveness of the forced swim test.	Shareholder	Against	For
8.	Shareholder proposal to amend the bylaws to require an independent board chair.	Shareholder	For	Against
9.	Shareholder proposal on board diversity requesting disclosures of specific minimum qualifications and board nominee skills, experience, and ideological perspective.	Shareholder	Against	For
10.	Shareholder proposal to publish feasibility report on incorporating public concern over drug prices into senior executive compensation arrangements.	Shareholder	Against	For
11.	Shareholder proposal to implement a bonus deferral policy.	Shareholder	Against	For
12.	Shareholder proposal to disclose clawbacks on executive incentive compensation due to misconduct.	Shareholder	Against	For

ESPERION THERAPEUTICS INC

Security	29664W105	Meeting Type	Annual
Ticker Symbol	ESPR	Meeting Date	28-May-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Class I Director: Daniel Janney	Management	For	For
1B.	Election of Class I Director: Tim M. Mayleben	Management	For	For
1C.	Election of Class I Director: Mark E. McGovern, M.D., FACC, FACP	Management	For	For
1D.	Election of Class I Director: Tracy M. Woody	Management	For	For
2.	To approve the advisory resolution on the compensation of our named executive officers	Management	For	For
3.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020	Management	For	For
4.	To approve the 2020 Employee Stock Purchase Plan	Management	For	For

EXELIXIS, INC.

Security	30161Q104	Meeting Type	Annual
Ticker Symbol	EXEL	Meeting Date	20-May-2020
Record Date	23-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Charles Cohen, Ph.D.	Management	For	For
1B.	Election of Director: Carl B. Feldbaum, Esq.	Management	For	For
1C.	Election of Director: Maria C. Freire, Ph.D.	Management	For	For
1D.	Election of Director: Alan M. Garber, M.D., Ph.D.	Management	For	For
1E.	Election of Director: Vincent T. Marchesi, M.D., Ph.D.	Management	For	For
1F.	Election of Director: Michael M. Morrissey, Ph.D.	Management	For	For
1G.	Election of Director: Stelios Papadopoulos, Ph.D.	Management	For	For
1H.	Election of Director: George Poste, DVM, Ph.D., FRS	Management	For	For
1I.	Election of Director: Julie Anne Smith	Management	For	For
1J.	Election of Director: Lance Willsey, M.D.	Management	For	For
1K.	Election of Director: Jack L. Wyszomierski	Management	For	For
2.	To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 1, 2021.	Management	For	For
3.	To amend and restate the Exelixis 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance by 21,000,000 shares.	Management	For	For
4.	To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement.	Management	For	For

FIVE STAR SENIOR LIVING INC.

Security	33832D205	Meeting Type	Annual
Ticker Symbol	FVE	Meeting Date	09-Jun-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director (for Independent Director in Group I): Barbara D. Gilmore	Management	For	For
1.2	Election of Director (for Managing Director in Group I): Adam D. Portnoy	Management	For	For
2.	Approval of the Company's Amended and Restated 2014 Equity Compensation Plan.	Management	For	For
3.	Advisory vote to approve executive compensation.	Management	For	For
4.	Ratification of the appointment of RSM US LLP as independent auditors to serve for the 2020 fiscal year.	Management	For	For

GALERA THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	9-Jul-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Election of Lawrence Alleva to the Board of Directors	Management	For	For
2.	General Enabling Resolutions	Management	For	For

GALERA THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	16-Oct-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Form of Lock-Up Agreement	Management	For	For

GALERA THERAPEUTICS, INC.

Security	36338D108	Meeting Type	Annual
Ticker Symbol	GRTX	Meeting Date	09-Jun-2020
Record Date	16-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Michael Powell, Ph.D.		For	For
	2	Linda West		For	For
2.	To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.		Management	For	For

GILEAD SCIENCES, INC.

Security	375558103	Meeting Type	Annual
Ticker Symbol	GILD	Meeting Date	06-May-2020
Record Date	13-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Jacqueline K. Barton, Ph.D.	Management	For	For
1B.	Election of Director: Sandra J. Horning, M.D.	Management	For	For
1C.	Election of Director: Kelly A. Kramer	Management	For	For
1D.	Election of Director: Kevin E. Lofton	Management	For	For
1E.	Election of Director: Harish Manwani	Management	For	For
1F.	Election of Director: Daniel P. O'Day	Management	For	For
1G.	Election of Director: Richard J. Whitley, M.D.	Management	For	For
1H.	Election of Director: Per Wold-Olsen	Management	For	For
2.	To ratify the selection of Ernst & Young LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2020.	Management	For	For
3.	To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.	Management	For	For
4.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director.	Shareholder	For	Against
5.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board eliminate the ownership threshold for stockholders to request a record date to take action by written consent.	Shareholder	For	Against

HCA HEALTHCARE, INC.

Security	40412C101	Meeting Type	Annual
Ticker Symbol	HCA	Meeting Date	01-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Thomas F. Frist III	Management	For	For
1B.	Election of Director: Samuel N. Hazen	Management	For	For
1C.	Election of Director: Meg G. Crofton	Management	For	For
1D.	Election of Director: Robert J. Dennis	Management	For	For
1E.	Election of Director: Nancy-Ann DeParle	Management	For	For
1F.	Election of Director: William R. Frist	Management	For	For
1G.	Election of Director: Charles O. Holliday, Jr.	Management	For	For
1H.	Election of Director: Michael W. Michelson	Management	For	For
1I.	Election of Director: Wayne J. Riley, M.D.	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2020.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	To approve the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates.	Management	For	For
5.	To approve an amendment to our amended and restated certificate of incorporation to allow stockholders owning an aggregate of 15% of our outstanding common stock to request special meetings of stockholders.	Management	For	For
6.	Stockholder proposal, if properly presented at the meeting, requesting that the Board of Directors take the steps necessary to allow stockholders to act by written consent.	Shareholder	Against	For

HEALTHCARE REALTY TRUST INCORPORATED

Security	421946104	Meeting Type	Annual
Ticker Symbol	HR	Meeting Date	12-May-2020
Record Date	13-Mar-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Todd J. Meredith		For	For
	2	John V. Abbott		For	For
	3	Nancy H. Agee		For	For
	4	Edward H. Braman		For	For
	5	James J. Kilroy		For	For
	6	Peter F. Lyle, Sr.		For	For
	7	John Knox Singleton		For	For
	8	Bruce D. Sullivan		For	For
	9	Christann M. Vasquez		For	For
2.	To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2020 fiscal year.		Management	For	For
3.	To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the shareholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2020 Annual Meeting of Shareholders.		Management	For	For

HEALTHCARE TRUST OF AMERICA, INC.

Security	42225P501	Meeting Type	Annual
Ticker Symbol	HTA	Meeting Date	07-Jul-2020
Record Date	15-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Scott D. Peters	Management	For	For
1B.	Election of Director: W. Bradley Blair, II	Management	For	For
1C.	Election of Director: Vicki U. Booth	Management	For	For
1D.	Election of Director: H. Lee Cooper	Management	For	For
1E.	Election of Director: Warren D. Fix	Management	For	For
1F.	Election of Director: Peter N. Foss	Management	For	For
1G.	Election of Director: Jay P. Leupp	Management	For	For
1H.	Election of Director: Gary T. Wescombe	Management	For	For
2.	To approve, on an advisory vote, the compensation of our named executive officers.	Management	For	For
3.	To consider and vote upon the ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2020.	Management	For	For

HEALTHEQUITY, INC.

Security	42226A107	Meeting Type	Annual
Ticker Symbol	HQY	Meeting Date	25-Jun-2020
Record Date	04-May-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of director to serve until the 2021 annual meeting of stockholders: Robert W. Selander	Management	For	For
1.2	Election of director to serve until the 2021 annual meeting of stockholders: Jon Kessler	Management	For	For
1.3	Election of director to serve until the 2021 annual meeting of stockholders: Stephen D. Neeleman, M.D.	Management	For	For
1.4	Election of director to serve until the 2021 annual meeting of stockholders: Frank A. Corvino	Management	For	For
1.5	Election of director to serve until the 2021 annual meeting of stockholders: Adrian T. Dillon	Management	For	For
1.6	Election of director to serve until the 2021 annual meeting of stockholders: Evelyn Dilsaver	Management	For	For
1.7	Election of director to serve until the 2021 annual meeting of stockholders: Debra McCowan	Management	For	For
1.8	Election of director to serve until the 2021 annual meeting of stockholders: Ian Sacks	Management	For	For
1.9	Election of director to serve until the 2021 annual meeting of stockholders: Gayle Wellborn	Management	For	For
2.	To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2021.	Management	For	For
3.	To approve, on a non-binding, advisory basis, the fiscal 2020 compensation of our named executive officers.	Management	For	For

HEALTHPEAK PROPERTIES, INC

Security	42250P103	Meeting Type	Annual
Ticker Symbol	PEAK	Meeting Date	23-Apr-2020
Record Date	02-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Brian G. Cartwright	Management	For	For
1B.	Election of Director: Christine N. Garvey	Management	For	For
1C.	Election of Director: R. Kent Griffin, Jr.	Management	For	For
1D.	Election of Director: David B. Henry	Management	For	For
1E.	Election of Director: Thomas M. Herzog	Management	For	For
1F.	Election of Director: Lydia H. Kennard	Management	For	For
1G.	Election of Director: Sara G. Lewis	Management	For	For
1H.	Election of Director: Katherine M. Sandstrom	Management	For	For
2.	Approval, on an advisory basis, of 2019 executive compensation.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2020.	Management	For	For

HOLOGIC, INC.

Security	436440101	Meeting Type	Annual
Ticker Symbol	HOLX	Meeting Date	05-Mar-2020
Record Date	08-Jan-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Stephen P. MacMillan		For	For
	2	Sally W. Crawford		For	For
	3	Charles J. Dockendorff		For	For
	4	Scott T. Garrett		For	For
	5	Ludwig N. Hantson		For	For
	6	Namal Nawana		For	For
	7	Christiana Stamoulis		For	For
	8	Amy M. Wendell		For	For
2.	A non-binding advisory resolution to approve executive compensation.		Management	For	For
3.	Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2020.		Management	For	For

HUMANA INC.

Security	444859102	Meeting Type	Annual
Ticker Symbol	HUM	Meeting Date	23-Apr-2020
Record Date	24-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kurt J. Hilzinger	Management	For	For
1B.	Election of Director: Frank J. Bisignano	Management	For	For
1C.	Election of Director: Bruce D. Broussard	Management	For	For
1D.	Election of Director: Frank A. D'Amelio	Management	For	For
1E.	Election of Director: W. Roy Dunbar	Management	For	For
1F.	Election of Director: Wayne A. I. Frederick, M.D.	Management	For	For
1G.	Election of Director: John W. Garratt	Management	For	For
1H.	Election of Director: David A. Jones, Jr.	Management	For	For
1I.	Election of Director: Karen W. Katz	Management	For	For
1J.	Election of Director: William J. McDonald	Management	For	For
1K.	Election of Director: James J. O'Brien	Management	For	For
1L.	Election of Director: Marissa T. Peterson	Management	For	For
2.	The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.	Management	For	For
3.	Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2020 proxy statement.	Management	For	For

IDEXX LABORATORIES, INC.

Security	45168D104	Meeting Type	Annual
Ticker Symbol	IDXX	Meeting Date	06-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Rebecca M. Henderson, PhD	Management	For	For
1B.	Election of Director: Lawrence D. Kingsley	Management	For	For
1C.	Election of Director: Sophie V. Vandebroek, PhD	Management	For	For
2.	Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two).	Management	For	For
3.	Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).	Management	For	For

ILLUMINA, INC.

Security	452327109	Meeting Type	Annual
Ticker Symbol	ILMN	Meeting Date	27-May-2020
Record Date	30-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Caroline Dorsa	Management	For	For
1B.	Election of Director: Robert S. Epstein, M.D.	Management	For	For
1C.	Election of Director: Scott Gottlieb, M.D.	Management	For	For
1D.	Election of Director: Philip W. Schiller	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2021.	Management	For	For
3.	To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.	Management	For	For
4.	To approve, on an advisory basis, a stockholder proposal regarding political disclosures.	Shareholder	Against	For

ILLUMINOSS MEDICAL, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	1-Jul-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Amendment to Sixth Amended and Restated Certification of Incorporation	Management	For	For
2.	Amendment No. 5 to Amended and Restated Secured Note and Warrant Purchase Agreement	Management	For	For
3.	General Authorizing Resolution	Management	For	For

ILLUMINOSS MEDICAL, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	21-Apr-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Merger; Agreement and Plan of Merger	Management	For	For
2.	General Ratification and Authorization	Management	For	For

INCYTE CORPORATION

Security	45337C102	Meeting Type	Annual
Ticker Symbol	INCY	Meeting Date	26-May-2020
Record Date	01-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Julian C. Baker	Management	For	For
1.2	Election of Director: Jean-Jacques Bienaimé	Management	For	For
1.3	Election of Director: Paul J. Clancy	Management	For	For
1.4	Election of Director: Wendy L. Dixon	Management	For	For
1.5	Election of Director: Jacqualyn A. Fouse	Management	For	For
1.6	Election of Director: Paul A. Friedman	Management	For	For
1.7	Election of Director: Edmund P. Harrigan	Management	For	For
1.8	Election of Director: Katherine A. High	Management	For	For
1.9	Election of Director: Hervé Hoppenot	Management	For	For
2.	To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.	Management	For	For
3.	To approve an amendment to the Company's 1997 Employee Stock Purchase Plan.	Management	For	For
4.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2020.	Management	For	For
5.	To vote on a stockholder proposal, if properly presented, described in more detail in the proxy statement.	Shareholder	Against	For

INOGEN, INC.

Security	45780L104	Meeting Type	Annual
Ticker Symbol	INGN	Meeting Date	11-May-2020
Record Date	13-Mar-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Heath Lukatch, Ph.D.		For	For
	2	Raymond Huggenberger		For	For
2.	To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2020.		Management	For	For
3.	Approval on an advisory basis of our executive compensation for the fiscal year ended December 31, 2019.		Management	For	For

INTUITIVE SURGICAL, INC.

Security	46120E602	Meeting Type	Annual
Ticker Symbol	ISRG	Meeting Date	23-Apr-2020
Record Date	28-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Craig H. Barratt, Ph.D.	Management	For	For
1B.	Election of Director: Joseph C. Beery	Management	For	For
1C.	Election of Director: Gary S. Guthart, Ph.D.	Management	For	For
1D.	Election of Director: Amal M. Johnson	Management	For	For
1E.	Election of Director: Don R. Kania, Ph.D.	Management	For	For
1F.	Election of Director: Amy L. Ladd, M.D.	Management	For	For
1G.	Election of Director: Keith R. Leonard, Jr.	Management	For	For
1H.	Election of Director: Alan J. Levy, Ph.D.	Management	For	For
1I.	Election of Director: Jami Dover Nachtsheim	Management	For	For
1J.	Election of Director: Mark J. Rubash	Management	For	For
2.	To approve, by advisory vote, the compensation of the Company's Named Executive Officers.	Management	For	For
3.	The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
4.	To approve the Company's Amended and Restated 2010 Incentive Award Plan.	Management	For	For
5.	To approve the amendment of the Certificate of Incorporation to adopt simple majority voting provisions.	Management	For	For
6.	To approve the amendment of the Certificate of Incorporation to permit stockholders to call a special meeting.	Management	For	For

IO LIGHT HOLDINGS INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	29-Apr-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Shareholder rights	Management	For	For

IQVIA HOLDINGS INC.

Security	46266C105	Meeting Type	Annual
Ticker Symbol	IQV	Meeting Date	06-Apr-2020
Record Date	12-Feb-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Carol J. Burt		For	For
	2	Colleen A. Goggins		For	For
	3	Ronald A. Rittenmeyer		For	For
2.	An advisory (non-binding) vote to approve executive compensation.		Management	For	For
3.	The ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2020.		Management	For	For

JOHNSON & JOHNSON

Security	478160104	Meeting Type	Annual
Ticker Symbol	JNJ	Meeting Date	23-Apr-2020
Record Date	25-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Mary C. Beckerle	Management	For	For
1B.	Election Of Director: D. Scott Davis	Management	For	For
1C.	Election of Director: Ian E. L. Davis	Management	For	For
1D.	Election of Director: Jennifer A. Doudna	Management	For	For
1E.	Election of Director: Alex Gorsky	Management	For	For
1F.	Election of Director: Marillyn A. Hewson	Management	For	For
1G.	Election of Director: Hubert Joly	Management	For	For
1H.	Election of Director: Mark B. McClellan	Management	For	For
1I.	Election of Director: Anne M. Mulcahy	Management	For	For
1J.	Election of Director: Charles Prince	Management	For	For
1K.	Election of Director: A. Eugene Washington	Management	For	For
1L.	Election of Director: Mark A. Weinberger	Management	For	For
1M.	Election of Director: Ronald A. Williams	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation.	Management	For	For
3.	Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2020.	Management	For	For
4.	Amendment to the Restated Certificate of Incorporation to Permit Removal of Directors Without Cause.	Management	For	For
5.	Independent Board Chair	Shareholder	For	Against
6.	Report on Governance of Opioids-Related Risks	Shareholder	Against	For

LABORATORY CORP. OF AMERICA HOLDINGS

Security	50540R409	Meeting Type	Annual
Ticker Symbol	LH	Meeting Date	13-May-2020
Record Date	25-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kerrii B. Anderson	Management	For	For
1B.	Election of Director: Jean-Luc Bélingard	Management	For	For
1C.	Election of Director: Jeffrey A. Davis	Management	For	For
1D.	Election of Director: D. Gary Gilliland, M.D., Ph.D.	Management	For	For
1E.	Election of Director: Garheng Kong, M.D., Ph.D.	Management	For	For
1F.	Election of Director: Peter M. Neupert	Management	For	For
1G.	Election of Director: Richelle P. Parham	Management	For	For
1H.	Election of Director: Adam H. Schechter	Management	For	For
1I.	Election of Director: R. Sanders Williams, M.D.	Management	For	For
2.	To approve, by non-binding vote, executive compensation.	Management	For	For
3.	Ratification of the appointment of PricewaterhouseCoopers LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for 2020.	Management	For	For
4.	Shareholder proposal seeking the power for shareholders of 10% or more of our common stock to call a special shareholder meeting.	Shareholder	Against	For

LIGAND PHARMACEUTICALS INCORPORATED

Security	53220K504	Meeting Type	Annual
Ticker Symbol	LGND	Meeting Date	10-Jun-2020
Record Date	14-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Jason M. Aryeh		For	For
	2	Sarah Boyce		For	For
	3	Todd C. Davis		For	For
	4	Nancy R. Gray, Ph.D.		For	For
	5	John L. Higgins		For	For
	6	John W. Kozarich, Ph.D.		For	For
	7	John L. LaMattina, Ph.D		For	For
	8	Sunil Patel		For	For
	9	Stephen L. Sabba, M.D.		For	For
2.	Ratification of Ernst & Young LLP as Ligand's Independent Registered Public Accounting Firm.		Management	For	For
3.	Approval, on an advisory basis, of the Compensation of the Named Executive Officers.		Management	For	For

LTC PROPERTIES, INC.

Security	502175102	Meeting Type	Annual
Ticker Symbol	LTC	Meeting Date	27-May-2020
Record Date	13-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director to hold office until the 2021 Annual Meeting: Boyd W. Hendrickson	Management	For	For
1.2	Election of Director to hold office until the 2021 Annual Meeting: James J. Pieczynski	Management	For	For
1.3	Election of Director to hold office until the 2021 Annual Meeting: Devra G. Shapiro	Management	For	For
1.4	Election of Director to hold office until the 2021 Annual Meeting: Wendy L. Simpson	Management	For	For
1.5	Election of Director to hold office until the 2021 Annual Meeting: Timothy J. Triche, M.D.	Management	For	For
2.	Ratification of independent registered public accounting firm.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For

MCKESSON CORPORATION

Security	58155Q103	Meeting Type	Annual
Ticker Symbol	MCK	Meeting Date	31-Jul-2019
Record Date	04-Jun-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director for a one-year term: Dominic J. Caruso	Management	For	For
1b.	Election of Director for a one-year term: N. Anthony Coles, M.D.	Management	For	For
1c.	Election of Director for a one-year term: M. Christine Jacobs	Management	For	For
1d.	Election of Director for a one-year term: Donald R. Knauss	Management	For	For
1e.	Election of Director for a one-year term: Marie L. Knowles	Management	For	For
1f.	Election of Director for a one-year term: Bradley E. Lerman	Management	For	For
1g.	Election of Director for a one-year term: Edward A. Mueller	Management	For	For
1h.	Election of Director for a one-year term: Susan R. Salka	Management	For	For
1i.	Election of Director for a one-year term: Brian S. Tyler	Management	For	For
1j.	Election of Director for a one-year term: Kenneth E. Washington	Management	For	For
2.	Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2020.	Management	For	For
3.	Advisory vote on executive compensation.	Management	For	For
4.	Shareholder proposal on disclosure of lobbying activities and expenditures.	Shareholder	Against	For
5.	Shareholder proposal on 10% ownership threshold for calling special meetings of shareholders.	Shareholder	Against	For

MEDICAL PROPERTIES TRUST, INC.

Security	58463J304	Meeting Type	Annual
Ticker Symbol	MPW	Meeting Date	21-May-2020
Record Date	20-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Edward K. Aldag, Jr.	Management	For	For
1B.	Election of Director: G. Steven Dawson	Management	For	For
1C.	Election of Director: R. Steven Hamner	Management	For	For
1D.	Election of Director: Caterina A. Mozingo	Management	For	For
1E.	Election of Director: Elizabeth N. Pitman	Management	For	For
1F.	Election of Director: C. Reynolds Thompson, III	Management	For	For
1G.	Election of Director: D. Paul Sparks, Jr.	Management	For	For
1H.	Election of Director: Michael G. Stewart	Management	For	For
2.	To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
3.	Non-binding, advisory approval of the Company's executive compensation.	Management	For	For

MEDTRONIC PLC

Security	G5960L103	Meeting Type	Annual
Ticker Symbol	MDT	Meeting Date	06-Dec-2019
Record Date	10-Oct-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Richard H. Anderson	Management	For	For
1B.	Election of Director: Craig Arnold	Management	For	For
1C.	Election of Director: Scott C. Donnelly	Management	For	For
1D.	Election of Director: Andrea J. Goldsmith, Ph.D.	Management	For	For
1E.	Election of Director: Randall J. Hogan, III	Management	For	For
1F.	Election of Director: Omar Ishrak	Management	For	For
1G.	Election of Director: Michael O. Leavitt	Management	For	For
1H.	Election of Director: James T. Lenehan	Management	For	For
1I.	Election of Director: Geoffrey S. Martha	Management	For	For
1J.	Election of Director: Elizabeth G. Nabel, M.D.	Management	For	For
1K.	Election of Director: Denise M. O'Leary	Management	For	For
1L.	Election of Director: Kendall J. Powell	Management	For	For
2.	To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as Medtronic's independent auditor for fiscal year 2020 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.	Management	For	For
3.	To approve, in a non-binding advisory vote, named executive officer compensation (a "Say-on-Pay" vote).	Management	For	For
4.	To renew the Board's authority to issue shares.	Management	For	For
5.	To renew the Board's authority to opt out of pre-emption rights.	Management	For	For
6.	Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.	Management	For	For

MERCK & CO., INC.

Security	58933Y105	Meeting Type	Annual
Ticker Symbol	MRK	Meeting Date	26-May-2020
Record Date	27-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Leslie A. Brun	Management	For	For
1B.	Election of Director: Thomas R. Cech	Management	For	For
1C.	Election of Director: Mary Ellen Coe	Management	For	For
1D.	Election of Director: Pamela J. Craig	Management	For	For
1E.	Election of Director: Kenneth C. Frazier	Management	For	For
1F.	Election of Director: Thomas H. Glocer	Management	For	For
1G.	Election of Director: Risa Lavizzo-Mourey	Management	For	For
1H.	Election of Director: Paul B. Rothman	Management	For	For
1I.	Election of Director: Patricia F. Russo	Management	For	For
1J.	Election of Director: Christine E. Seidman	Management	For	For
1K.	Election of Director: Inge G. Thulin	Management	For	For
1L.	Election of Director: Kathy J. Warden	Management	For	For
1M.	Election of Director: Peter C. Wendell	Management	For	For
2.	Non-binding advisory vote to approve the compensation of our named executive officers.	Management	For	For
3.	Ratification of the appointment of the Company's independent registered public accounting firm for 2020.	Management	For	For
4.	Shareholder proposal concerning shareholder right to act by written consent.	Shareholder	Against	For
5.	Shareholder proposal regarding allocation of corporate tax savings.	Shareholder	Against	For

METTLER-TOLEDO INTERNATIONAL INC.

Security	592688105	Meeting Type	Annual
Ticker Symbol	MTD	Meeting Date	07-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Robert F. Spoerry	Management	For	For
1.2	Election of Director: Wah-Hui Chu	Management	For	For
1.3	Election of Director: Domitille Doat-Le Bigot	Management	For	For
1.4	Election of Director: Olivier A. Filliol	Management	For	For
1.5	Election of Director: Elisha W. Finney	Management	For	For
1.6	Election of Director: Richard Francis	Management	For	For
1.7	Election of Director: Michael A. Kelly	Management	For	For
1.8	Election of Director: Thomas P. Salice	Management	For	For
2.	RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	Management	For	For
3.	ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION.	Management	For	For

MYLAN N.V.

Security	N59465109	Meeting Type	Special
Ticker Symbol	MYL	Meeting Date	15-Jun-2020
Record Date	05-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the Combination Proposal: (A) Approval of the Mylan Merger; (B) Approval of the Share Sale; (C) Approval of the Mylan Newco Liquidation; (D) Approval of the Alternative Transaction Structure; and (E) Approval of the Discharge of Directors (in each case with the foregoing capitalized terms as defined in the accompanying proxy statement).	Management	For	For
2.	Adoption of a non-binding, advisory resolution to adopt the compensation that will or may be paid or become payable to Mylan's named executive officers in connection with, or following, the consummation of the Combination as described in the proxy statement.	Management	For	For
3.	Adoption of a non-binding, advisory resolution to adopt certain features of Newco's governance which will replace the corresponding features of Mylan's governance, effective upon the closing of the Combination, relating to (i) the right of stockholders to nominate directors and make other stockholder proposals at stockholder meetings and (ii) director terms and stockholder removal of directors.	Management	For	For
4.	Adoption of a non-binding, advisory resolution to adopt certain features of Newco's governance which will replace the corresponding features of Mylan's governance, effective upon the closing of the Combination, relating to the right of stockholders to call special meetings of stockholders.	Management	For	For

MYLAN N.V.

Security	N59465109	Meeting Type	Special
Ticker Symbol	MYL	Meeting Date	30-Jun-2020
Record Date	02-Jun-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Appointment of the Director: Heather Bresch	Management	For	For
1B.	Appointment of the Director: Hon. Robert J. Cindrich	Management	For	For
1C.	Appointment of the Director: Robert J. Coury	Management	For	For
1D.	Appointment of the Director: JoEllen Lyons Dillon	Management	For	For
1E.	Appointment of the Director: Neil Dimick, C.P.A.	Management	For	For
1F.	Appointment of the Director: Melina Higgins	Management	For	For
1G.	Appointment of the Director: Harry A. Korman	Management	For	For
1H.	Appointment of the Director: Rajiv Malik	Management	For	For
1I.	Appointment of the Director: Richard Mark, C.P.A.	Management	For	For
1J.	Appointment of the Director: Mark W. Parrish	Management	For	For
1K.	Appointment of the Director: Pauline van der Meer Mohr	Management	For	For
1L.	Appointment of the Director: Randall L. (Pete) Vanderveen, Ph.D.	Management	For	For
1M.	Appointment of the Director: Sjoerd S. Vollebregt	Management	For	For
2.	Approval, on an advisory basis, of the compensation of the named executive officers of the Company.	Management	For	For
3.	Adoption of the Dutch annual accounts for fiscal year 2019.	Management	For	For
4.	Ratification of the selection of Deloitte & Touche LLP as Mylan's independent registered public accounting firm for fiscal year 2020.	Management	For	For
5.	Instruction to Deloitte Accountants B.V. for the audit of Mylan's Dutch statutory annual accounts for fiscal year 2020.	Management	For	For
6.	Authorization of the Board to acquire shares in the capital of the Company.	Management	For	For
7.	Delegation to the Board of the authority to issue ordinary shares and grant rights to subscribe for ordinary shares in the capital of the Company and to exclude or restrict pre-emptive rights.	Management	For	For
E1E	Approval of the Combination Proposal. ...(due to space limits, see proxy material for full proposal).	Management	For	For
E2E	Adoption of a non-binding, advisory resolution to adopt the compensation that will or may be paid or become payable to Mylan's named executive officers in connection with, or following, the consummation of the Combination as described in the proxy statement.	Management	For	For
E3E	Adoption of a non-binding, advisory resolution to adopt certain features of Newco's governance which will replace the corresponding features of Mylan's governance, effective upon the closing of the Combination, relating to (i) the right of stockholders to nominate directors and make other stockholder proposals at stockholder meetings and (ii) director terms and stockholder removal of directors.	Management	For	For
E4E	Adoption of a non-binding, advisory resolution to adopt certain features of Newco's governance which will replace the corresponding features of Mylan's governance, effective upon the closing of the Combination, relating to the right of stockholders to call special meetings of stockholders.	Management	For	For

NATIONAL HEALTH INVESTORS, INC.

Security	63633D104	Meeting Type	Annual
Ticker Symbol	NHI	Meeting Date	06-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: W. Andrew Adams	Management	For	For
1B.	Election of Director: Robert A. McCabe, Jr.	Management	For	For
1C.	Election of Director: Charlotte A. Swafford	Management	For	For
1D.	Election of Director: Robert G. Adams	Management	For	For
2.	Approve the Amendment to the Articles of Incorporation to increase the number of authorized shares.	Management	For	For
3.	Approve the advisory resolution approving the compensation of the named executive officers as disclosed in the accompanying proxy statement.	Management	For	For
4.	Ratify the audit committee's selection of BDO USA, LLP as independent registered public accounting firm for year ending December 31, 2020.	Management	For	For

NEKTAR THERAPEUTICS

Security	640268108	Meeting Type	Annual
Ticker Symbol	NKTR	Meeting Date	17-Jun-2020
Record Date	20-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Karin Eastham	Management	For	For
1B.	Election of Director: Myriam J. Curet	Management	For	For
1C.	Election of Director: Howard W. Robin	Management	For	For
2.	To approve an amendment of our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 10,000,000 shares.	Management	For	For
3.	To approve an amendment and restatement of our Amended and Restated Employee Stock Purchase Plan to increase the aggregate number of shares of common stock authorized under the plan by 1,000,000 shares.	Management	For	For
4.	To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
5.	To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote).	Management	For	For

NEW SENIOR INVESTMENT GROUP INC.

Security	648691103	Meeting Type	Annual
Ticker Symbol	SNR	Meeting Date	28-May-2020
Record Date	03-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Stuart A. McFarland		For	For
	2	Robert F. Savage		For	For
2.	Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for New Senior Investment Group Inc. for fiscal year 2020.		Management	For	For
3.	Approval of an advisory vote on 2019 executive compensation.		Management	For	For
4.	Approval of an advisory vote on the frequency of future advisory votes on executive compensation.		Management	1 Year	For
5.	Approval of amendments to our Certificate of Incorporation and Bylaws to provide for the annual election of all directors.		Management	For	For
6.	Approval of amendments to our Bylaws to implement majority voting in uncontested director elections.		Management	For	For
7A.	Approval of an amendment to our Certificate of Incorporation to eliminate the supermajority voting requirement to amend certain provisions of our Certificate of Incorporation.		Management	For	For
7B.	Approval of amendments to our Certificate of Incorporation and Bylaws to eliminate the supermajority voting requirements to amend our Bylaws.		Management	For	For
7C.	Approval of amendments to our Certificate of Incorporation and Bylaws to eliminate the supermajority voting requirements to remove directors for cause and appoint directors in the event the entire Board of Directors is removed.		Management	For	For

OCULIS SA

Security	Meeting Type	Extraordinary General Meeting
Ticker Symbol	Meeting Date	26-Nov-2019
Record Date

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Ordinary Share Capital Increase	Management	For	For
2.	Conditional Share Capital Increase	Management	For	For

OCULIS SA

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	9-Mar-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Ordinary Share Capital Increase	Management	For	For
2.	Conditional Share Capital Increase	Management	For	For

OCULIS SA

Security	N/A	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	25-Jun-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of Annual Report including Financial Statements	Management	For	For
2.	Appropriation of Balance Sheet Result 2019	Management	For	For
3.	Discharge of the Members of the Board and Management	Management	For	For
4.	Re-Election of Board of Directors	Management	For	For
5.	Re-Election of the Auditors	Management	For	For

OMEGA HEALTHCARE INVESTORS, INC.

Security	681936100	Meeting Type	Annual
Ticker Symbol	OHI	Meeting Date	11-Jun-2020
Record Date	13-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Kapila K. Anand		For	For
	2	Craig R. Callen		For	For
	3	Barbara B. Hill		For	For
	4	Edward Lowenthal		For	For
	5	C. Taylor Pickett		For	For
	6	Stephen D. Plavin		For	For
	7	Burke W. Whitman		For	For
2.	Ratification of Independent Auditors Ernst & Young LLP for fiscal year 2020.		Management	For	For
3.	Approval, on an Advisory Basis, of Executive Compensation.		Management	For	For

PERKINELMER, INC.

Security	714046109	Meeting Type	Annual
Ticker Symbol	PKI	Meeting Date	28-Apr-2020
Record Date	28-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Peter Barrett	Management	For	For
1B.	Election of Director: Samuel R. Chapin	Management	For	For
1C.	Election of Director: Sylvie Grégoire, PharmD	Management	For	For
1D.	Election of Director: Alexis P. Michas	Management	For	For
1E.	Election of Director: Prahlad R. Singh, PhD	Management	For	For
1F.	Election of Director: Michel Vounatsos	Management	For	For
1G.	Election of Director: Frank Witney, PhD	Management	For	For
1H.	Election of Director: Pascale Witz	Management	For	For
2.	To ratify the selection of Deloitte & Touche LLP as PerkinElmer's independent registered public accounting firm for the current fiscal year.	Management	For	For
3.	To approve, by non-binding advisory vote, our executive compensation.	Management	For	For

PFIZER INC.

Security	717081103	Meeting Type	Annual
Ticker Symbol	PFE	Meeting Date	23-Apr-2020
Record Date	25-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Ronald E. Blaylock	Management	For	For
1B.	Election of Director: Albert Bourla	Management	For	For
1C.	Election of Director: W. Don Cornwell	Management	For	For
1D.	Election of Director: Joseph J. Echevarria	Management	For	For
1E.	Election of Director: Scott Gottlieb	Management	For	For
1F.	Election of Director: Helen H. Hobbs	Management	For	For
1G.	Election of Director: Susan Hockfield	Management	For	For
1H.	Election of Director: James M. Kilts	Management	For	For
1I.	Election of Director: Dan R. Littman	Management	For	For
1J.	Election of Director: Shantanu Narayen	Management	For	For
1K.	Election of Director: Suzanne Nora Johnson	Management	For	For
1L.	Election of Director: James Quincey	Management	For	For
1M.	Election of Director: James C. Smith	Management	For	For
2.	Ratify the selection of KPMG LLP as independent registered public accounting firm for 2020	Management	For	For
3.	2020 advisory approval of executive compensation	Management	For	For
4.	Shareholder proposal regarding right to act by written consent	Shareholder	Against	For
5.	Shareholder proposal regarding enhancing proxy access	Shareholder	Against	For
6.	Shareholder proposal regarding report on lobbying activities	Shareholder	Against	For
7.	Shareholder proposal regarding independent chair policy	Shareholder	For	Against
8.	Shareholder proposal regarding gender pay gap	Shareholder	Against	For
9.	Election of Director: Susan Desmond-Hellmann	Management	For	For

PHYSICIANS REALTY TRUST

Security	71943U104	Meeting Type	Annual
Ticker Symbol	DOC	Meeting Date	06-May-2020
Record Date	13-Mar-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	John T. Thomas		For	For
	2	Tommy G. Thompson		For	For
	3	Stanton D. Anderson		For	For
	4	Mark A. Baumgartner		For	For
	5	Albert C. Black, Jr.		For	For
	6	William A Ebinger, M.D		For	For
	7	Pamela J. Kessler		For	For
	8	Richard A. Weiss		For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.		Management	For	For
3.	To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement.		Management	For	For

PIERIS PHARMACEUTICALS, INC.

Security	720795103	Meeting Type	Annual
Ticker Symbol	PIRS	Meeting Date	31-Jul-2019
Record Date	03-Jun-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	James Geraghty		For	For
	2	Ann Barbier, M.D.,Ph.D.		For	For
2.	Approve the Company's 2019 Employee, Director and Consultant Equity Incentive Plan.		Management	For	For
3.	Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2019.		Management	For	For

PIERIS PHARMACEUTICALS, INC.

Security	720795103	Meeting Type	Annual
Ticker Symbol	PIRS	Meeting Date	23-Jun-2020
Record Date	24-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Stephen S. Yoder		For	For
	2	Michael Richman		For	For
	3	Matthew L. Sherman, M.D		For	For
2.	Approve the Company's 2020 Employee, Director and Consultant Equity Incentive Plan.		Management	For	For
3.	Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.		Management	For	For
4	Approve, on non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in this proxy statement.		Management	For	For
5.	The preferred frequency for future non-binding advisory votes to approve the compensation of the Company's named executive officers.		Management	1 Year	For

PRA HEALTH SCIENCES, INC.

Security	69354M108	Meeting Type	Annual
Ticker Symbol	PRAH	Meeting Date	18-May-2020
Record Date	20-Mar-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Colin Shannon		For	For
	2	James C. Momtazee		For	For
	3	Alexander G. Dickinson		For	For
2.	To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2020.		Management	For	For
3.	Approval, in a non-binding advisory vote, of the compensation paid to the Company's named executive officers.		Management	For	For
4.	Approval of the PRA Health Sciences, Inc. 2020 Stock Incentive Plan.		Management	For	For

PUMA BIOTECHNOLOGY, INC.

Security	74587V107	Meeting Type	Annual
Ticker Symbol	PBYI	Meeting Date	09-Jun-2020
Record Date	15-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Alan H. Auerbach		For	For
	2	Ann C. Miller		For	For
	3	Michael P. Miller		For	For
	4	Jay M. Moyes		For	For
	5	Hugh O'Dowd		For	For
	6	Adrian M. Senderowicz		For	For
	7	Troy E. Wilson		For	For
	8	Frank E. Zavrl		For	For
2.	Ratification of the selection of KPMG LLP as independent registered public accounting firm of Puma Biotechnology, Inc. for the fiscal year ending December 31, 2020.		Management	For	For
3.	Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement.		Management	For	For

QUEST DIAGNOSTICS INCORPORATED

Security	74834L100	Meeting Type	Annual
Ticker Symbol	DGX	Meeting Date	19-May-2020
Record Date	20-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Vicky B. Gregg	Management	For	For
1B.	Election of Director: Wright L. Lassiter III	Management	For	For
1C.	Election of Director: Timothy L. Main	Management	For	For
1D.	Election of Director: Denise M. Morrison	Management	For	For
1E.	Election of Director: Gary M. Pfeiffer	Management	For	For
1F.	Election of Director: Timothy M. Ring	Management	For	For
1G.	Election of Director: Stephen H. Rusckowski	Management	For	For
1H.	Election of Director: Daniel C. Stanzione	Management	For	For
1I.	Election of Director: Helen I. Torley	Management	For	For
1J.	Election of Director: Gail R. Wilensky	Management	For	For
2.	An advisory resolution to approve the executive officer compensation disclosed in the Company's 2020 proxy statement	Management	For	For
3.	Ratification of the appointment of our independent registered public accounting firm for 2020	Management	For	For

RAINIER THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	11-Jul-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Authorization and Approval of Unsecured Note Amendment and Secured Note Financing	Management	For	For
2.	Security Interest Grant to Note Recipients	Management	For	For
3.	General Authorizing Resolution	Management	For	For

RAINIER THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	30-Oct-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Adoption of Change in Control Retention Plan	Management	For	For
2.	General Authorizing Resolution	Management	For	For

RAINIER THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	3-Mar-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Asset Purchase Agreement	Management	For	For
2.	Appointment of Seller's Representative	Management	For	For
3.	Waiver of Notice Requirement	Management	For	For
4.	Series A and Series B Stockholder Waiver	Management	For	For
5.	Interested Party Transactions	Management	For	For
6.	General Authorizing Resolution	Management	For	For

RIANIER THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	19-May-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Adoption of Plan of Complete Liquidation, Liquidation and Dissolution	Management	For	For
2.	Interested Party Transactions	Management	For	For
3.	Waiver of Notice Requirement	Management	For	For
4.	General Authorizing Resolution	Management	For	For

RALLYBIO HOLDINGS, LLC

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	14-May-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Series B Expansion	Management	For	For

REGENERON PHARMACEUTICALS, INC.

Security	75886F107	Meeting Type	Annual
Ticker Symbol	REGN	Meeting Date	12-Jun-2020
Record Date	14-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: N. Anthony Coles, M.D.	Management	For	For
1B.	Election of Director: Joseph L. Goldstein, M.D.	Management	For	For
1C.	Election of Director: Christine A. Poon	Management	For	For
1D.	Election of Director: P. Roy Vagelos, M.D.	Management	For	For
1E.	Election of Director: Huda Y. Zoghbi, M.D.	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
3.	Proposal to approve the Second Amended and Restated Regeneron Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan.	Management	For	For
4.	Proposal to approve, on an advisory basis, executive compensation.	Management	For	For

REGENXBIO INC.

Security	75901B107	Meeting Type	Annual
Ticker Symbol	RGNX	Meeting Date	29-May-2020
Record Date	30-Mar-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Donald J. Hayden, Jr.		For	For
	2	A.N. Karabelas, Ph.D.		For	For
	3	Daniel Tassé		For	For
2.	To ratify the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the Company for the year ending December 31, 2020.		Management	For	For
3.	Advisory vote on the compensation paid to the Company's named executive officers.		Management	For	For

RESMED INC.

Security	761152107	Meeting Type	Annual
Ticker Symbol	RMD	Meeting Date	21-Nov-2019
Record Date	26-Sep-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Carol Burt	Management	For	For
1B.	Election of Director: Jan De Witte	Management	For	For
1C.	Election of Director: Richard Sulpizio	Management	For	For
2.	Ratify our appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2020.	Management	For	For
3.	Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay").	Management	For	For

SABRA HEALTH CARE REIT, INC.

Security	78573L106	Meeting Type	Annual
Ticker Symbol	SBRA	Meeting Date	09-Jun-2020
Record Date	20-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Craig A. Barbarosh	Management	For	For
1B.	Election of Director: Robert A. Ettl	Management	For	For
1C.	Election of Director: Michael J. Foster	Management	For	For
1D.	Election of Director: Ronald G. Geary	Management	For	For
1E.	Election of Director: Lynne S. Katzmann	Management	For	For
1F.	Election of Director: Raymond J. Lewis	Management	For	For
1G.	Election of Director: Jeffrey A. Malehorn	Management	For	For
1H.	Election of Director: Richard K. Matros	Management	For	For
1I.	Election of Director: Milton J. Walters	Management	For	For
2.	Approval of amendments to the Sabra Health Care REIT, Inc. 2009 Performance Incentive Plan.	Management	For	For
3.	Approval of an amendment to Sabra's charter to increase the number of authorized shares of common stock, par value $0.01 per share, of Sabra from 250,000,000 to 500,000,000.	Management	For	For
4.	Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
5.	Approval, on an advisory basis, of the compensation of Sabra's named executive officers.	Management	For	For

STERIS PLC

Security	G8473T100	Meeting Type	Annual
Ticker Symbol	STE	Meeting Date	30-Jul-2019
Record Date	30-May-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Re-election of Director: Richard C. Breeden	Management	For	For
1b.	Re-election of Director: Cynthia L. Feldmann	Management	For	For
1c.	Re-election of Director: Dr. Jacqueline B. Kosecoff	Management	For	For
1d.	Re-election of Director: David B. Lewis	Management	For	For
1e.	Re-election of Director: Walter M Rosebrough, Jr.	Management	For	For
1f.	Re-election of Director: Dr. Nirav R. Shah	Management	For	For
1g.	Re-election of Director: Dr. Mohsen M. Sohi	Management	For	For
1h.	Re-election of Director: Dr. Richard M. Steeves	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2020.	Management	For	For
3.	To appoint Ernst & Young Chartered Accountants as the Company's Irish statutory auditor under the Act to hold office until the conclusion of the Company's next Annual General Meeting.	Management	For	For
4.	To authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company's Irish statutory auditor.	Management	For	For
5.	To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2019.	Management	For	For

STERIS PLC

Security	G8473T100	Meeting Type	Annual
Ticker Symbol	STE	Meeting Date	28-Jul-2020
Record Date	29-May-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Re-election of Director: Richard C. Breeden	Management	For	For
1b.	Re-election of Director: Cynthia L. Feldmann	Management	For	For
1c.	Re-election of Director: Dr. Jacqueline B. Kosecoff	Management	For	For
1d.	Re-election of Director: David B. Lewis	Management	For	For
1e.	Re-election of Director: Walter M Rosebrough, Jr.	Management	For	For
1f.	Re-election of Director: Dr. Nirav R. Shah	Management	For	For
1g.	Re-election of Director: Dr. Mohsen M. Sohi	Management	For	For
1h.	Re-election of Director: Dr. Richard M. Steeves	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2021.	Management	For	For
3.	To appoint Ernst & Young Chartered Accountants as the Company's Irish statutory auditor under the Act to hold office until the conclusion of the Company's next Annual General Meeting.	Management	For	For
4.	To authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company's Irish statutory auditor.	Management	For	For
5.	To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2020.	Management	For	For

STRYKER CORPORATION

Security	863667101	Meeting Type	Annual
Ticker Symbol	SYK	Meeting Date	05-May-2020
Record Date	06-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Mary K. Brainerd	Management	For	For
1B.	Election of Director: Srikant M. Datar, Ph.D.	Management	For	For
1C.	Election of Director: Roch Doliveux, DVM	Management	For	For
1D.	Election of Director: Allan C. Golston(Lead Independent Director)	Management	For	For
1E.	Election of Director: Kevin A. Lobo(Chairman of the Board)	Management	For	For
1F.	Election of Director: Sherilyn S. McCoy	Management	For	For
1G.	Election of Director: Andrew K. Silvernail	Management	For	For
1H.	Election of Director: Lisa M. Skeete Tatum	Management	For	For
1I.	Election of Director: Ronda E. Stryker	Management	For	For
1J.	Election of Director: Rajeev Suri	Management	For	For
2.	Ratify appointment of Ernst & Young LLP as our independent registered public accounting firm for 2020.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	Non-management employee representation on the Board of Directors.	Management	Against	For

TELEFLEX INCORPORATED

Security	879369106	Meeting Type	Annual
Ticker Symbol	TFX	Meeting Date	01-May-2020
Record Date	02-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: George Babich, Jr.	Management	For	For
1B.	Election of Director: Gretchen R. Haggerty	Management	For	For
1C.	Election of Director: Liam J. Kelly	Management	For	For
2.	Approval, on an advisory basis, of named executive officer compensation.	Management	For	For
3.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2020.	Management	For	For

TENET HEALTHCARE CORPORATION

Security	88033G407	Meeting Type	Annual
Ticker Symbol	THC	Meeting Date	28-May-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Ronald A. Rittenmeyer	Management	For	For
1B.	Election of Director: J. Robert Kerrey	Management	For	For
1C.	Election of Director: Lloyd J. Austin, III	Management	For	For
1D.	Election of Director: James L. Bierman	Management	For	For
1E.	Election of Director: Richard W. Fisher	Management	For	For
1F.	Election of Director: Meghan M. FitzGerald	Management	For	For
1G.	Election of Director: Christopher S. Lynch	Management	For	For
1H.	Election of Director: Richard J. Mark	Management	For	For
1I.	Election of Director: Tammy Romo	Management	For	For
1J.	Election of Director: Nadja Y. West	Management	For	For
2.	Proposal to approve, on an advisory basis, the company's executive compensation.	Management	For	For	��
3.	Proposal to ratify the selection of Deloitte & Touche LLP as independent registered public accountants for the year ending December 31, 2020.	Management	For	For
4.	Shareholder proposal regarding an independent chairman.	Shareholder	Against	For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Security	881624209	Meeting Type	Annual
Ticker Symbol	TEVA	Meeting Date	09-Jun-2020
Record Date	09-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Dr. Sol J. Barer	Management	For	For
1B.	Election of Director: Jean-Michel Halfon	Management	For	For
1C.	Election of Director: Nechemia (Chemi) J. Peres	Management	For	For
1D.	Election of Director: Janet S. Vergis	Management	For	For
2.	To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.	Management	For	For
3.	To approve Teva's 2020 Long-Term Equity-Based Incentive Plan, substantially in the form attached as Appendix A to the Proxy Statement.	Management	For	For
4.	To approve an amendment to the terms of office and employment of Teva's President and Chief Executive Officer.	Management	For	For
5.	To approve an amendment to Teva's Articles of Association.	Management	For	For
6.	To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2021 annual meeting of shareholders.	Management	For	For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Security	881624209	Meeting Type	Annual
Ticker Symbol	TEVA	Meeting Date	09-Jun-2020
Record Date	30-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Dr. Sol J. Barer	Management	For	For
1B.	Election of Director: Jean-Michel Halfon	Management	For	For
1C.	Election of Director: Nechemia (Chemi) J. Peres	Management	For	For
1D.	Election of Director: Janet S. Vergis	Management	For	For
2.	To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.	Management	For	For
3.	To approve Teva's 2020 Long-Term Equity-Based Incentive Plan, substantially in the form attached as Appendix A to the Proxy Statement.	Management	For	For
4.	To approve an amendment to the terms of office and employment of Teva's President and Chief Executive Officer.	Management	For	For
5.	To approve an amendment to Teva's Articles of Association.	Management	For	For
6.	To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2021 annual meeting of shareholders.	Management	For	For

THERMO FISHER SCIENTIFIC INC.

Security	883556102	Meeting Type	Annual
Ticker Symbol	TMO	Meeting Date	20-May-2020
Record Date	27-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Marc N. Casper	Management	For	For
1B.	Election of Director: Nelson J. Chai	Management	For	For
1C.	Election of Director: C. Martin Harris	Management	For	For
1D.	Election of Director: Tyler Jacks	Management	For	For
1E.	Election of Director: Judy C. Lewent	Management	For	For
1F.	Election of Director: Thomas J. Lynch	Management	For	For
1G.	Election of Director: Jim P. Manzi	Management	For	For
1H.	Election of Director: James C. Mullen	Management	For	For
1I.	Election of Director: Lars R. Sørensen	Management	For	For
1J.	Election of Director: Debora L. Spar	Management	For	For
1K.	Election of Director: Scott M. Sperling	Management	For	For
1L.	Election of Director: Dion J. Weisler	Management	For	For
2.	An advisory vote to approve named executive officer compensation.	Management	For	For
3.	Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2020.	Management	For	For

UNITEDHEALTH GROUP INCORPORATED

Security	91324P102	Meeting Type	Annual
Ticker Symbol	UNH	Meeting Date	01-Jun-2020
Record Date	07-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Richard T. Burke	Management	For	For
1B.	Election of Director: Timothy P. Flynn	Management	For	For
1C.	Election of Director: Stephen J. Hemsley	Management	For	For
1D.	Election of Director: Michele J. Hooper	Management	For	For
1E.	Election of Director: F. William McNabb III	Management	For	For
1F.	Election of Director: Valerie C. Montgomery Rice, M.D.	Management	For	For
1G.	Election of Director: John H. Noseworthy, M.D.	Management	For	For
1H.	Election of Director: Glenn M. Renwick	Management	For	For
1I.	Election of Director: David S. Wichmann	Management	For	For
1J.	Election of Director: Gail R. Wilensky, Ph.D.	Management	For	For
2.	Advisory approval of the Company's executive compensation.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2020.	Management	For	For
4.	Approval of the UnitedHealth Group 2020 Stock Incentive Plan.	Management	For	For
5.	If properly presented at the 2020 Annual Meeting of Shareholders, the shareholder proposal set forth in the proxy statement requesting any material amendment to the Company's Bylaws be subject to a non-binding shareholder vote.	Shareholder	Against	For

UNIVERSAL HEALTH REALTY INCOME TRUST

Security	91359E105	Meeting Type	Annual
Ticker Symbol	UHT	Meeting Date	03-Jun-2020
Record Date	06-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Alan B. Miller		For	For
	2	Robert F. McCadden		For	For
2.	Advisory (nonbinding) vote to approve named executive officer compensation.		Management	For	For
3.	To approve an amendment to the Universal Health Realty Income Trust Amended and Restated 2007 Restricted Stock Plan.		Management	For	For
4.	To ratify the selection of KPMG LLP, as the Trust's independent registered public accounting firm for the fiscal year ending December 31, 2020.		Management	For	For

VENTAS, INC.

Security	92276F100	Meeting Type	Annual
Ticker Symbol	VTR	Meeting Date	18-May-2020
Record Date	20-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval, on an advisory basis, of our executive compensation.	Management	For	For
2A.	Election of Director: Melody C. Barnes	Management	For	For
2B.	Election of Director: Debra A. Cafaro	Management	For	For
2C.	Election of Director: Jay M. Gellert	Management	For	For
2D.	Election of Director: Richard I. Gilchrist	Management	For	For
2E.	Election of Director: Matthew J. Lustig	Management	For	For
2F.	Election of Director: Roxanne M. Martino	Management	For	For
2G.	Election of Director: Sean P. Nolan	Management	For	For
2H.	Election of Director: Walter C. Rakowich	Management	For	For
2I.	Election of Director: Robert D. Reed	Management	For	For
2J.	Election of Director: James D. Shelton	Management	For	For
3.	Ratification of the selection of KPMG LLP as the independent registered public accounting firm for fiscal year 2020.	Management	For	For

VERTEX PHARMACEUTICALS INCORPORATED

Security	92532F100	Meeting Type	Annual
Ticker Symbol	VRTX	Meeting Date	03-Jun-2020
Record Date	09-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Sangeeta Bhatia	Management	For	For
1B.	Election of Director: Lloyd Carney	Management	For	For
1C.	Election of Director: Alan Garber	Management	For	For
1D.	Election of Director: Terrence Kearney	Management	For	For
1E.	Election of Director: Reshma Kewalramani	Management	For	For
1F.	Election of Director: Yuchun Lee	Management	For	For
1G.	Election of Director: Jeffrey Leiden	Management	For	For
1H.	Election of Director: Margaret McGlynn	Management	For	For
1I.	Election of Director: Diana McKenzie	Management	For	For
1J.	Election of Director: Bruce Sachs	Management	For	For
2.	Ratification of Ernst & Young LLP as our independent Registered Public Accounting firm for the year ending December 31, 2020.	Management	For	For
3.	Advisory vote on named executive officer compensation.	Management	For	For
4.	Shareholder proposal, if properly presented at the meeting, requesting that we prepare a report on our policies and activities with respect to lobbying.	Shareholder	Against	For

WATERS CORPORATION

Security	941848103	Meeting Type	Annual
Ticker Symbol	WAT	Meeting Date	12-May-2020
Record Date	18-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Linda Baddour	Management	For	For
1B.	Election of Director: Michael J Berendt, PH.D	Management	For	For
1C.	Election of Director: Edward Conard	Management	For	For
1D.	Election of Director: Laurie H. Glimcher, M.D	Management	For	For
1E.	Election of Director: Gary E. Hendrickson	Management	For	For
1F.	Election of Director: Christopher A. Kuebler	Management	For	For
1G.	Election of Director: Christopher J O'Connell	Management	For	For
1H.	Election of Director: Flemming Ornskov, M.D., M.P.H	Management	For	For
1I.	Election of Director: JoAnn A. Reed	Management	For	For
1J.	Election of Director: Thomas P. Salice	Management	For	For
2.	To ratify the selection of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2020.	Management	For	For
3.	To approve, by non-binding vote, named executive officer compensation.	Management	For	For
4.	To approve the 2020 Equity Incentive Plan.	Management	For	For

WELLTOWER INC.

Security	95040Q104	Meeting Type	Annual
Ticker Symbol	WELL	Meeting Date	30-Apr-2020
Record Date	03-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kenneth J. Bacon	Management	For	For
1B.	Election of Director: Thomas J. DeRosa	Management	For	For
1C.	Election of Director: Karen B. DeSalvo	Management	For	For
1D.	Election of Director: Jeffrey H. Donahue	Management	For	For
1E.	Election of Director: Sharon M. Oster	Management	For	For
1F.	Election of Director: Sergio D. Rivera	Management	For	For
1G.	Election of Director: Johnese M. Spisso	Management	For	For
1H.	Election of Director: Kathryn M. Sullivan	Management	For	For
2.	The ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year 2020.	Management	For	For
3.	The approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the 2020 Proxy Statement.	Management	For	For

XENCOR, INC.

Security	98401F105	Meeting Type	Annual
Ticker Symbol	XNCR	Meeting Date	25-Jun-2020
Record Date	27-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Bassil I. Dahiyat		For	For
	2	Ellen G. Feigal		For	For
	3	Kevin C. Gorman		For	For
	4	Kurt A. Gustafson		For	For
	5	Yujiro S. Hata		For	For
	6	A. Bruce Montgomery		For	For
	7	Richard J. Ranieri		For	For
	8	Dagmar Rosa-Bjorkeson		For	For
2.	Proposal to ratify RSM US LLP as the independent registered public accounting firm for 2020		Management	For	For
3.	Proposal to approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials		Management	For	For

ZIMMER BIOMET HOLDINGS, INC.

Security	98956P102	Meeting Type	Annual
Ticker Symbol	ZBH	Meeting Date	08-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Christopher B. Begley	Management	For	For
1B.	Election of Director: Betsy J. Bernard	Management	For	For
1C.	Election of Director: Gail K. Boudreaux	Management	For	For
1D.	Election of Director: Michael J. Farrell	Management	For	For
1E.	Election of Director: Larry C. Glasscock	Management	For	For
1F.	Election of Director: Robert A. Hagemann	Management	For	For
1G.	Election of Director: Bryan C. Hanson	Management	For	For
1H.	Election of Director: Arthur J. Higgins	Management	For	For
1I.	Election of Director: Maria Teresa Hilado	Management	For	For
1J.	Election of Director: Syed Jafry	Management	For	For
1K.	Election of Director: Michael W. Michelson	Management	For	For
2.	Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2020.	Management	For	For
3.	Advisory vote to approve named executive officer compensation (Say on Pay).	Management	For	For

ZOETIS INC.

Security	98978V103	Meeting Type	Annual
Ticker Symbol	ZTS	Meeting Date	20-May-2020
Record Date	26-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Gregory Norden	Management	For	For
1B.	Election of Director: Louise M. Parent	Management	For	For
1C.	Election of Director: Kristin C. Peck	Management	For	For
1D.	Election of Director: Robert W. Scully	Management	For	For
2.	Advisory vote to approve our executive compensation (Say on Pay).	Management	For	For
3.	Advisory vote on the frequency of future advisory votes on executive compensation (Say on Pay frequency).	Management	1 Year	For
4.	Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2020.	Management	For	For

ZYLA LIFE SCIENCES

Security	98986F108	Meeting Type	Annual
Ticker Symbol	ZCOR	Meeting Date	17-Dec-2019
Record Date	24-Oct-2019

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Timothy P. Walbert		For	For
	2	Todd Holmes		For	For
	3	Joseph McInnis		For	For
	4	Matthew Pauls		For	For
	5	Gary M. Phillips, M.D.		For	For
	6	Andrea Heslin Smiley		For	For
	7	Todd N. Smith		For	For
2.	To ratify the selection of Ernst & Young LLP a Zyla Life Sciences' independent registered public accounting firm for the fiscal year ending December 31, 2019.		Management	For	For

ZYLA LIFE SCIENCES

Security	98986F108	Meeting Type	Special
Ticker Symbol	ZCOR	Meeting Date	19-May-2020
Record Date	15-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To adopt the Agreement and Plan of Merger, dated as of March 16, 2020 (as it may be amended from time to time, referred to as the "Merger Agreement"), by and among Zyla Life Sciences, Assertio Therapeutics, Inc., Alligator Zebra Holdings Inc., Zebra Merger Sub and Alligator Merger Sub, Inc.	Management	For	For
2.	To approve the adjournment from time to time of the Zyla Special Meeting, if necessary to solicit additional proxies if there are not sufficient votes to approve Proposal 1 at the time of the Zyla Special Meeting or any adjournment or postponement thereof.	Management	For	For
3.	To approve, on an advisory (non-binding) basis, the compensation that will or may be paid or provided by Zyla Life Sciences to its named executive officers in connection with the merger contemplated by the Merger Agreement	Management	For	For

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)	Tekla Healthcare Opportunites Fund
By (Signature and Title)*
	/s/ Daniel R. Omstead
	(Daniel R. Omstead, President)
Date	8/17/20

*Print the name and title of each signing officer under his or her signature.